A detailed history of Bridgeway Capital Management, LLC transactions in Biote Corp. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 121,053 shares of BTMD stock, worth $357,106. This represents 0.01% of its overall portfolio holdings.

Number of Shares
121,053
Previous 50,000 142.11%
Holding current value
$357,106
Previous $166,000 192.77%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$3.25 - $4.28 $230,922 - $304,106
71,053 Added 142.11%
121,053 $486,000
Q1 2025

May 15, 2025

BUY
$3.23 - $6.2 $161,500 - $310,000
50,000 New
50,000 $166,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $22.3M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.